BECHINI, ANGELA
 Distribuzione geografica
Continente #
NA - Nord America 13.183
EU - Europa 13.019
AS - Asia 7.026
SA - Sud America 909
OC - Oceania 215
AF - Africa 179
Continente sconosciuto - Info sul continente non disponibili 2
Totale 34.533
Nazione #
US - Stati Uniti d'America 13.039
RU - Federazione Russa 4.133
PL - Polonia 3.259
IT - Italia 2.106
SG - Singapore 2.011
CN - Cina 1.472
HK - Hong Kong 1.165
KR - Corea 866
IE - Irlanda 864
SE - Svezia 744
BR - Brasile 735
DE - Germania 470
FI - Finlandia 330
IN - India 301
VN - Vietnam 295
GB - Regno Unito 232
AU - Australia 205
FR - Francia 190
JO - Giordania 182
CH - Svizzera 172
TR - Turchia 168
ID - Indonesia 132
UA - Ucraina 115
NL - Olanda 114
AR - Argentina 74
CA - Canada 66
ES - Italia 59
JP - Giappone 59
IR - Iran 49
TH - Thailandia 48
MX - Messico 47
CI - Costa d'Avorio 46
PH - Filippine 43
ZA - Sudafrica 38
BD - Bangladesh 32
TW - Taiwan 28
EC - Ecuador 25
CZ - Repubblica Ceca 24
BE - Belgio 23
PE - Perù 23
MY - Malesia 21
GR - Grecia 20
IQ - Iraq 20
LT - Lituania 19
MA - Marocco 19
AT - Austria 18
SA - Arabia Saudita 18
PK - Pakistan 16
BG - Bulgaria 15
HR - Croazia 14
PT - Portogallo 14
PY - Paraguay 14
VE - Venezuela 14
KE - Kenya 13
LV - Lettonia 13
KZ - Kazakistan 11
UZ - Uzbekistan 11
BH - Bahrain 10
NO - Norvegia 10
RO - Romania 10
SI - Slovenia 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
CO - Colombia 9
SC - Seychelles 9
AL - Albania 8
EG - Egitto 8
TN - Tunisia 8
AZ - Azerbaigian 7
NP - Nepal 7
NZ - Nuova Zelanda 7
BJ - Benin 6
CY - Cipro 6
HU - Ungheria 6
IL - Israele 6
OM - Oman 6
DO - Repubblica Dominicana 5
EE - Estonia 5
ET - Etiopia 5
NG - Nigeria 5
UY - Uruguay 5
AM - Armenia 4
DZ - Algeria 4
GA - Gabon 4
GH - Ghana 4
PA - Panama 4
TT - Trinidad e Tobago 4
AO - Angola 3
CR - Costa Rica 3
DK - Danimarca 3
FJ - Figi 3
GE - Georgia 3
GT - Guatemala 3
JM - Giamaica 3
KG - Kirghizistan 3
LU - Lussemburgo 3
MN - Mongolia 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
Totale 34.493
Città #
Santa Clara 3.730
Warsaw 3.236
Singapore 1.386
Ashburn 1.186
Hong Kong 969
Fairfield 862
Dublin 857
Chandler 724
Seoul 712
Beijing 446
Cambridge 371
Seattle 361
Woodbridge 350
Hefei 344
Florence 342
Houston 309
Buffalo 286
Wilmington 281
Princeton 239
Los Angeles 238
Lawrence 210
Altamura 207
Moscow 197
Mumbai 195
Boston 188
Jacksonville 180
Ann Arbor 153
Bern 151
Munich 147
New York 146
Boardman 144
Melbourne 133
Rome 119
Milan 108
Kent 102
Jakarta 100
Shanghai 98
Medford 96
Turku 85
Ho Chi Minh City 82
Paris 80
San Diego 75
Izmir 71
Dallas 68
Helsinki 67
Hanoi 60
São Paulo 60
Clifton 57
Dong Ket 56
London 51
The Dalles 50
Sydney 48
Redondo Beach 47
Abidjan 46
Tokyo 44
Naples 43
Bremen 41
Norwalk 41
San Jose 38
Falkenstein 37
Dearborn 36
Bangkok 35
Frankfurt am Main 31
Lappeenranta 29
Toronto 29
Hillsboro 28
Phoenix 28
Rio de Janeiro 28
Brooklyn 27
Amsterdam 26
Chicago 26
Bengaluru 25
Council Bluffs 24
Genoa 24
Falls Church 23
Barcelona 22
Tianjin 22
Andover 21
Yubileyny 21
Bari 20
Lima 20
Montreal 20
Palermo 20
Seodaemun-gu 20
Ankara 19
Bologna 19
Seo-gu 17
Atlanta 16
Brussels 16
Gangnam-gu 16
Hamburg 16
Padova 16
Salvador 16
Ancona 15
Catania 15
Manchester 15
Pisa 15
Pune 15
Cagliari 14
Guangzhou 14
Totale 22.009
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 1.306
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 529
HPV vaccination for boys? A systematic review of economic studies 395
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 368
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 316
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 287
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 281
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 279
Human papilloma virus vaccination: impact and recommendations across the world. 278
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 273
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 273
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 272
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 262
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 254
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 246
The epidemiology of mumps in Italy 245
The epidemiology of Varicella Zoster Virus infection in Italy. 242
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 237
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 234
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 233
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 231
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 222
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 221
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 211
Human Papilloma Virus Vaccination and Cervical Screening in the Italian Regions: An Overview of the Current State of the Art 206
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 206
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 204
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 201
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 200
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 191
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 191
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries 190
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 190
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 187
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 186
Measles outbreak in Grosseto, central Italy, 2006. 184
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 181
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 180
Recommended vaccinations for asplenic and hyposplenic adult patients 178
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 175
Progress in Italy in control and elimination of measles and congenital rubella. 171
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 168
INCREASING RESISTANCE IN COMMENSAL ESCHERICHIA COLI, BOLIVIA AND PERU 165
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 165
Genomic, Molecular, and Phenotypic Characterization of Arthrobacter sp. OVS8, an Endophytic Bacterium Isolated from and Contributing to the Bioactive Compound Content of the Essential Oil of the Medicinal Plant Origanum vulgare L 159
Progress in Italy in control and elimination of measles and congenital rubella. 159
Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project 159
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 157
Knowledge and training of Italian students in Healthcare Settings on COVID-19 vaccines and vaccination strategies, one year after the immunization campaign 156
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 156
Determinants of Actual COVID-19 Vaccine Uptake in a Cohort of Essential Workers: An Area-Based Longitudinal Study in the Province of Prato, Italy 154
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 154
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 153
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 153
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 152
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 151
Knowledge of University Students in Health Care Settings on Vaccines and Vaccinations Strategies: Impact Evaluation of a Specific Educational Training Course during the COVID-19 Pandemic Period in Italy 150
Health literacy and vaccination: A systematic review 150
Attitudes and perceptions of Italian Students in Healthcare Settings on COVID-19 vaccines and vaccinations strategies, one year after the immunization campaign 149
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 149
Gli operatori sanitari degli ospedali fiorentini: protetti o non protetti verso morbillo, parotite, rosolia e varicella? 149
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 149
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 147
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 147
An overview on the implementation of HPV vaccination in Europe. 146
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 145
Attitudes and Perceptions of University Students in Healthcare Settings towards Vaccines and Vaccinations Strategies during the COVID-19 Pandemic Period in Italy 144
Vaccination coverage during pregnancy and factors associated with refusal of recommended vaccinations: An Italian cross sectional study 142
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 142
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 141
Key points for the decision maker 141
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 140
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 140
Efficacy of HPV Vaccination Regarding Vulvar and Vaginal Recurrences in Previously Treated Women: The Need for Further Evidence 139
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 139
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 138
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 137
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 137
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 137
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 136
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 135
Application of socio-economic-health deprivation index, analysis of mortality and influenza vaccination coverage in the elderly population of Tuscany 135
La sorveglianza di laboratorio dei casi di sospetto morbillo in Toscana dal 2004 al 2012. 134
Antibacterial activity of Arthrobacter strains isolated from Great Gobi A Strictly Protected Area, Mongolia 133
The role of health literacy in covid-19 preventive behaviors and infection risk perception: Evidence from a population-based sample of essential frontline workers during the lockdown in the province of prato (tuscany, italy) 133
Le abitudini sessuali e i fattori di rischio per l'infezione da HPV degli studenti di Infermieristica dell'Università di Firenze: uno studio pilota 132
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 132
Epatite B e C: pratiche di counselling e referral in soggetti migranti (progetto HEPSCREEN) 132
Reasons for the Intention to Refuse COVID-19 Vaccination and Their Association with Preferred Sources of Information in a Nationwide, Population-Based Sample in Italy, before COVID-19 Vaccines Roll Out 132
Antibacterial Properties of Bacterial Endophytes Isolated from the Medicinal Plant Origanum heracleoticum L 131
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 131
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 130
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 130
Focusing on the implementation of 21st century vaccines for adults 130
A study of hepatitis a seroprevalence in a paediatric and adolescent population of the province of florence (Italy) in the period 2017–2018 confirms tuscany a low endemic area 130
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 130
Factors influencing sars-cov-2 vaccine acceptance and hesitancy in a population-based sample in Italy 130
The First 30 Years of the Universal Hepatitis-B Vaccination-Program in Italy: A Health Strategy with a Relevant and Favorable Economic-Profile 129
The burden of disease of Herpes Zoster in Tuscany 129
Evaluating the costs and benefits of pneumococcal vaccination in adults 129
Totale 19.338
Categoria #
all - tutte 95.337
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 95.337


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.188 0 0 0 0 0 234 96 148 176 308 77 149
2021/20221.452 55 180 82 54 38 38 47 128 40 59 270 461
2022/20234.050 344 616 219 259 250 706 543 235 529 28 134 187
2023/20242.545 88 201 296 177 227 292 195 340 109 228 222 170
2024/202512.170 467 1.277 796 1.816 3.319 1.625 243 648 534 367 491 587
2025/20266.858 1.552 1.712 1.089 937 1.469 99 0 0 0 0 0 0
Totale 34.804